First quarter 2022 results

First quarter 2022 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.

(14:30 - 16:00 CET / 8:30am – 10am EST)


Paul Hudson

Chief Executive Officer

Jean-Baptiste de Chatillon

Chief Financial Officer

Bill Sibold

Specialty Care

Olivier Charmeil

General Medicines

John Reed


Thomas Triomphe


Julie Van Ongevalle

Consumer Healthcare

Roy Papatheodorou

General Counsel


Paul Hudson comments on first quarter 2022 results

Highlights of the first quarter 2022 results

We’re off to a good start in 2022 thanks to a strong commitment to our strategy. We’re proud of the progress made in Immunology, with a broad pipeline of 13 potential new treatments in development.

Paul Hudson

Chief Executive Officer, Sanofi


Replay Available


Press release


Q1 2022 Income statements

Q1 2022 net sales by GBU, franchise, geographic region and product

R&D appendix

Download infographic

Q1 2022 Memorandum for modelling purposes


Investor Relations
investor.relations (at) 

More contact information